Ozempic and metformin: the same, or taken together?

First, the most common mix-up

If you were prescribed metformin years ago — for polycystic ovaries, for prediabetes, for type 2 diabetes — and someone is now talking to you about Ozempic, it is natural to wonder whether it is "a newer version of the same thing." It isn't. They are two different medications that do different things, and in practice they are almost always used one on top of the other, not one instead of the other.

Metformin is a daily pill. It helps your body respond to its own insulin and tells the liver to release less sugar. Some women lose a little weight on it, but it is not a weight-loss drug.

Ozempic is semaglutide, a GLP-1 injected once a week. It works on appetite, on how fast the stomach empties, and on how the pancreas responds after a meal. It is approved for type 2 diabetes, and the same molecule, under another name and at other doses, is approved for weight.

Can you take them together?

Yes — and that is how it was studied. The clinical trials behind the Ozempic label tested it added to the metformin people were already taking, not replacing it: in those studies semaglutide was compared with other options in people who stayed on metformin in the background¹. The semaglutide pill was studied the same way: the large trial tested it as an add-on to metformin in 1,864 adults with type 2 diabetes².

That is the thing many moms do not know walking into the appointment: the question is rarely "metformin or Ozempic?" It is "metformin alone, or metformin plus a GLP-1?"

What happened in a trial of women with PCOS

This is the study I care most about for the readers of this page, because it is women, with polycystic ovary syndrome, comparing exactly those two options.

One hundred women with overweight or obesity and PCOS were randomly assigned to metformin alone (1,000 mg twice a day) or metformin plus semaglutide (1 mg a week) for 16 weeks. The combination group lost an average of 6.1 kg (about 13 lb); the metformin-only group lost 2.3 kg (about 5 lb). The combination also did more for testosterone, for a visceral-fat index and for C-reactive protein, and more women got their menstrual cycle back³.

Two honest notes about that trial, because it earns them: it was open-label (the women knew what they were taking), and 80% completed it. A strong result — not a settled one.

The wider picture is more modest. A 2026 systematic review pooled 11 trials of GLP-1s in women with PCOS and found a BMI reduction of about 1.4 points against the control group, with low certainty; no difference for cholesterol or triglycerides, and not enough evidence to conclude anything about menstrual regularity or excess hair⁴. In other words: the weight comes down; the rest is not yet solidly shown.

What the Ozempic label says about combining them

Three concrete things, all from the current prescribing information:

1. 1.The low-blood-sugar warning does not name metformin. The label warns of a higher risk of hypoglycemia when Ozempic is combined with insulin or with medicines that make the pancreas release insulin (sulfonylureas). Metformin is not on that list¹. If you take one of those alongside metformin, that is a separate conversation with your clinician.
2. 2.Ozempic slows stomach emptying, and the label acknowledges this could affect how oral medications are absorbed — though in the studies the effect did not reach a clinically relevant degree¹. Metformin is oral. Worth mentioning if you notice anything change.
3. 3.The label's own trials were run on a metformin background, so the combination is not an experiment of yours — it is the scenario that was tested¹.

What I would ask at the appointment

• "Do I keep the metformin as is, or does the dose change?" (The usual answer is to keep it, but let the person who prescribed it say so.)
• "If my stomach acts up, how do I tell which one is doing it?" Both are known for upsetting the stomach early on; starting the GLP-1 at the lowest dose, as the label directs, helps keep the two apart.
• If you have PCOS and want to conceive: GLP-1s are stopped before trying — the Ozempic label asks for at least two months before a planned pregnancy¹ — so a "metformin plus GLP-1" plan comes with an end date worth putting on the calendar from day one.

In short

Not the same thing. Almost always taken together. In women with PCOS, adding semaglutide to metformin took off considerably more weight in a 16-week trial, though the evidence for everything else is still weak. And the Ozempic label sees no combination problem in metformin: the low-blood-sugar risk it does warn about is with insulin and sulfonylureas.